145 related articles for article (PubMed ID: 17469025)
1. Polymorphisms in NQO1 and the clinical course of urinary bladder neoplasms.
Sanyal S; Ryk C; De Verdier PJ; Steineck G; Larsson P; Onelöv E; Hemminki K; Kumar R
Scand J Urol Nephrol; 2007; 41(3):182-90. PubMed ID: 17469025
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in DNA repair and metabolic genes in bladder cancer.
Sanyal S; Festa F; Sakano S; Zhang Z; Steineck G; Norming U; Wijkström H; Larsson P; Kumar R; Hemminki K
Carcinogenesis; 2004 May; 25(5):729-34. PubMed ID: 14688016
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
[TBL] [Abstract][Full Text] [Related]
4. Lack of association of NQO1 and GSTP1 polymorphisms with multiple myeloma risk.
Maggini V; Buda G; Galimberti S; Martino A; Orciuolo E; Morabito F; Bono R; Barale R; Petrini M; Rossi AM
Leuk Res; 2008 Jun; 32(6):988-90. PubMed ID: 18061666
[TBL] [Abstract][Full Text] [Related]
5. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
[TBL] [Abstract][Full Text] [Related]
6. Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes.
Skjelbred CF; Svendsen M; Haugan V; Eek AK; Clausen KO; Kure EH; Tuimala JT; Svendsen MV; Norppa H; Hansteen IL
Carcinogenesis; 2011 Mar; 32(3):399-405. PubMed ID: 21097530
[TBL] [Abstract][Full Text] [Related]
7. Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy.
Toncheva DI; Von Ahsen N; Atanasova SY; Dimitrov TG; Armstrong VW; Oellerich M
J Nephrol; 2004; 17(3):384-9. PubMed ID: 15365958
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic.
Steinmaus C; Moore LE; Shipp M; Kalman D; Rey OA; Biggs ML; Hopenhayn C; Bates MN; Zheng S; Wiencke JK; Smith AH
J Toxicol Environ Health A; 2007 Jan; 70(2):159-70. PubMed ID: 17365577
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.
Lin J; Spitz MR; Wang Y; Schabath MB; Gorlov IP; Hernandez LM; Pillow PC; Grossman HB; Wu X
Carcinogenesis; 2004 Sep; 25(9):1639-47. PubMed ID: 15117811
[TBL] [Abstract][Full Text] [Related]
10. [Genetic polymorphisms of MPO, NQO1, GSTP1, UGT1A6 associated with susceptibility of chronic benzene poisoning].
Sun P; Zhang Z; Wan J; Shao M
Wei Sheng Yan Jiu; 2007 Jan; 36(1):11-5. PubMed ID: 17424838
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer.
Timofeeva M; Kropp S; Sauter W; Beckmann L; Rosenberger A; Illig T; Jäger B; Mittelstrass K; Dienemann H; ; Bartsch H; Bickeböller H; Chang-Claude J; Risch A; Wichmann HE
Int J Cancer; 2010 Oct; 127(7):1547-61. PubMed ID: 20091863
[TBL] [Abstract][Full Text] [Related]
12. Association of the GSTP1 and NQO1 polymorphisms and head and neck squamous cell carcinoma risk.
Cho CG; Lee SK; Nam SY; Lee MS; Lee SW; Choi EK; Park HJ; Kim SY
J Korean Med Sci; 2006 Dec; 21(6):1075-9. PubMed ID: 17179690
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of GSTT1, GSTM1, and NQO1 genes and diabetes mellitus risk in Chinese population.
Wang G; Zhang L; Li Q
Biochem Biophys Res Commun; 2006 Mar; 341(2):310-3. PubMed ID: 16413497
[TBL] [Abstract][Full Text] [Related]
14. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population.
Ouerhani S; Oliveira E; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; El Gaaied AB; Prata MJ
Cancer Genet Cytogenet; 2007 Jul; 176(1):48-53. PubMed ID: 17574963
[TBL] [Abstract][Full Text] [Related]
16. Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina.
Moore LE; Wiencke JK; Bates MN; Zheng S; Rey OA; Smith AH
Cancer Lett; 2004 Aug; 211(2):199-207. PubMed ID: 15219943
[TBL] [Abstract][Full Text] [Related]
17. Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis.
Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
Cancer Epidemiol; 2012 Dec; 36(6):e373-9. PubMed ID: 22770696
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk.
Hung RJ; Boffetta P; Brennan P; Malaveille C; Gelatti U; Placidi D; Carta A; Hautefeuille A; Porru S
Carcinogenesis; 2004 Jun; 25(6):973-8. PubMed ID: 14729580
[TBL] [Abstract][Full Text] [Related]
19. NAD(P)H:Quinone oxidoreductase-1 C609T polymorphism analysis in human superficial bladder cancers: relationship of genotype status to NQO1 phenotype and clinical response to Mitomycin C.
Basu S; Brown JE; Flannigan GM; Gill JH; Loadman PM; Martin SW; Naylor B; Puri R; Scally AJ; Seargent JM; Shah T; Phillips RM
Int J Oncol; 2004 Oct; 25(4):921-7. PubMed ID: 15375541
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stress.
Martin NJ; Collier AC; Bowen LD; Pritsos KL; Goodrich GG; Arger K; Cutter G; Pritsos CA
Mutat Res; 2009 Mar; 674(1-2):93-100. PubMed ID: 18950733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
